No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 1.3x · 10Y median 4.8x · 3rd percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 17
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T17:57:57.186Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for QT Imaging Holdings, Inc. (QTI) stock was $2.64 as of Oct 6, 2026, 1:51 PM EDT, up 0.96% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +12.0%
QT Imaging Holdings, Inc. is dedicated to the research, development, and manufacturing of advanced automated systems for breast imaging.
Medical - Devices · Novato, CA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Nov 9, 2026
34 days away
EPS Estimate
-0.11
Revenue Est.
$10.72M
Last Quarter Results
EPS
$-0.75
vs Estimate
$-0.22
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1QTI | $36.28M | $2.63 | +0.96% | +11.96% | N/A | N/A | N/A |
| 2NEPH | $36.37M | $3.35 | -5.63% | -25.47% | -15.93% | +1.80% | vs QTI |
| 3ELTX | $36.51M | $1.92 | -0.26% | -82.46% | N/A | N/A | vs QTI |
| 4DCGO | $35.77M | $0.36 | -0.79% | -71.09% | -48.40% | N/A | vs QTI |
| 5EUDA | $35.71M | $19.12 | +10.53% | -61.04% | N/A | N/A | vs QTI |
| 6EDSA | $37.09M | $3.85 | -1.53% | +52.43% | -39.88% | -40.32% | vs QTI |
forward FY estimate
N/A
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$7.43M
vs Estimate
$7.60M
Consensus Rating
Based on 3 analysts
Average Price Target
$10.40
+294.7% upside
Low
$8.00
Current
$2.63
High
$13.20
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.12 | $-0.10 | $-0.07 | 2 |
| Quarter ending Dec 2026 | $0.00 | $0.01 | $0.01 | 2 |
| Quarter ending Mar 2027 | $-0.06 | $-0.06 | $-0.05 | 1 |
| Quarter ending Jun 2027 | $-0.04 | $-0.04 | $-0.04 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-1.21 | $-1.11 | $-1.01 | 1 |
| FY 2027 | $0.11 | $0.12 | $0.13 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $10.90M | $11.35M | $11.80M | 2 |
| Quarter ending Dec 2026 | $13.74M | $13.92M | $14.10M | 2 |
| Quarter ending Mar 2027 | $11.80M | $11.96M | $12.11M | 1 |
| Quarter ending Jun 2027 | $13.84M | $14.02M | $14.20M | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $38.60M | $39.20M | $39.80M | 2 |
| FY 2027 | $56.91M | $63.10M | $69.30M | 2 |
